A Study of Breast Cancer Risk Factors and Outcomes of People in Florida

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorMemorial Sloan Kettering Cancer Center

About this trial

The purpose of this study is to understand why different people have different risks and outcomes for breast cancer and non-breast cancer.

Eligibility criteria

This trial accepts healthy volunteers

Qualifiers

Patients with BIRADS 0-5, seen in breast radiology clinic at University of Miami (UM), Sylvester Comprehensive Cancer Center (SCCC), Jackson Health Systems (JHS) for biopsy.

Any new breast patient seen at UM/SCCC or JHS will be invited to participate in the study.

Men and women 18 years of age and older are eligible to participate in the study.

Disqualifiers

Patients who are less than 18 years of age will be considered ineligible.

Patients unable to complete the survey.

Trial population

University of Miami treating clinicians will identify participants (anyone meeting inclusion criteria listed above) during their regularly scheduled visits (Breast radiology at time of initial biopsy, Surgery clinic visit, Medical Oncology clinic visit) or in the pre-operative waiting area prior to surgery.

Trial design

Design model

Cohort

Time perspective

Prospective

Treatments tested in this trial

  • Biospecimen Collection

    Other intervention

    Blood collection at baseline and time of surgery

  • Surgical Tissue Collection

    Diagnostic test

    Tissue collection will be attempted at time of surgery

  • Survey Collection

    Behavioral

    Survey collection at baseline, post-surgery, at 1, 3 and 5 year follow up visits

Treatment groups

800 Participants
are divided into 1 treatment group
Group A: Participants with BIRADS 0-53 interventions

Trial outcomes

Primary outcomes

1

Clinical characteristic of participants (survey)

The purpose of this study is to prospectively collect and store clinical data, blood and tissue samples, and participant survey data to evaluate (epi) genomic and non-genomic causes of disparity.

Time frame
Up to 5 years

Secondary outcomes

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.